Full Text View
Tabular View
No Study Results Posted
Related Studies
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
This study has been terminated.
( funding discontinued by sponsor )
Study NCT00265200   Information provided by James Graham Brown Cancer Center

First Received on December 12, 2005.   Last Updated on April 5, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma, Non-Small Cell Lung
Carcinoma, Small Cell Lung
Metastases
Additional conditions recognized in this trial
Bone Marrow Diseases
Bone Neoplasms
Carcinoma
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Lung Neoplasms
Neoplasm Metastasis
Neoplasms, Second Primary
Small Cell Lung Carcinoma
More general conditions related to this trial
Bone Diseases
Bronchial Neoplasms
Carcinoma, Bronchogenic
Hematologic Diseases
Lung Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplastic Processes
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
zoledronic acid
Additional drug interventions recognized in this trial
Diphosphonates
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
James Graham Brown Cancer Center
University of Louisville
Novartis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services